SCPH scPharmaceuticals
- 5.435
- +0.125+2.35%
scPharmaceuticals News
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D
scPharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Nokes Rachael
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%), etc.
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 10-Q: Q2 2024 Earnings Report
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 424B5: Prospectus
scPharmaceuticals | 424B5: Prospectus
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nokes Rachael
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 8-K: Current report
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A.
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Agger Mette Kirstine
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Abraham William Tober
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director VEITINGER KLAUS R DR
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Baylor-Henry Minnie
Analysis
Price Target
No Data
No Data